Malkovich's Venice Win Halved Norton's Supporting Actor Odds

---

Edward Norton's Best Supporting Actor Odds Halved in 72 Hours: Here's Why the Category Is Being Redrawn

Edward Norton's chances of winning Best Supporting Actor have dropped from 20% to 10% in three days on Kalshi and Polymarket, and nothing in his own category caused the move. Norton has not lost a critics' prize, suffered a campaign setback, or been overtaken by a breakout festival performance in Supporting Actor. The catalyst sits in an entirely different race.

Norton's implied probability dropped from 20% to 10% between September 21 and September 24, according to data across Kalshi and Polymarket. The move coincides almost perfectly with John Malkovich's Best Actor surge following his September 12 Volpi Cup win at the Venice Film Festival for Martin McDonagh's "Wild Horse Nine." Malkovich jumped from 24% to 36% in Best Actor over the ten days after Venice. Norton's Supporting Actor contract began its slide in the same window.

The platform-level spread tells its own story. Norton sits at 6% on Kalshi and 15% on Polymarket, a 9-point gap that points to fast-moving repricing rather than settled consensus. His period low of 6% means the contract briefly traded at less than a third of its value from just days earlier before recovering slightly.

---

John Malkovich Won at Venice, and the Shockwave Hit Edward Norton's Category

The mechanism here is not mysterious, but it is counterintuitive. Malkovich and Norton are not competing in the same Oscar category. They will not appear on the same ballot line. Yet when a dominant frontrunner emerges in one major category, prediction market participants routinely liquidate peripheral positions to concentrate capital on higher-conviction bets. Malkovich's 12-point surge in Best Actor created exactly that kind of gravity well.

Malkovich has never been nominated for Best Actor. His two prior Oscar nominations came in Supporting, for "Places in the Heart" (1984) and "In the Line of Fire" (1993), and he lost both. That detail makes his current 36% Best Actor price all the more notable: the market is pricing a first-time lead nominee as the category favorite, six months before the ceremony. That level of conviction pulls capital from everywhere, including from mid-tier Supporting Actor contracts like Norton's.

This cross-category ripple effect has precedent. In years where a single performance dominates the awards conversation (think Heath Ledger in 2008 or Cate Blanchett in 2022), adjacent categories often see repricing as bettors consolidate. Norton's drop is not evidence of weakness in his own campaign. It is evidence of Malkovich's strength radiating outward.

---

Paul Giamatti Is Now the Best Supporting Actor Frontrunner: What 37% Odds Actually Mean

The competitive picture in Best Supporting Actor has shifted decisively. Paul Giamatti now leads the category at 37% on Kalshi and 39% on Polymarket, placing him at roughly quadruple Norton's current implied probability. Robert Pattinson holds 15%, and Sam Rockwell sits at 8%.

Prediction-market view

Live prices, venue by venue

Compare the latest YES price at each venue. Check market rules, liquidity, and fees before trading.

Edward Norton

Consensus YES price across 2 venues

8%average

KalshiBest YES price7¢Polymarket15.2¢

Tie

Consensus YES price across 1 venues

1%average

KalshiBest YES price1¢

Channing Tatum

Consensus YES price across 1 venues

1%average

KalshiBest YES price1¢

Paul Giamatti

Consensus YES price across 2 venues

37%average

KalshiBest YES price35¢Polymarket40¢

Current new-user offer · Kalshi

Get a $35 trading bonusCode PRED35

New users only. Eligibility restrictions and terms apply.

View current offer

The gap between Giamatti and Norton has widened from roughly 17 to 19 points a week ago to approximately 27 to 29 points today. That is no longer a competitive two-horse race. Norton has moved from plausible challenger to mid-tier long shot in the span of a news cycle.

For context, a 10% implied probability in an Oscar acting category six months before the ceremony is not negligible. It places Norton in a tier comparable to actors who typically receive nominations but do not win. The market sees him as a real contender for the shortlist but not for the trophy. Whether that assessment holds depends on what happens between now and the nomination announcement.

---

The Case for Norton Being Undervalued, and What Would Change the Market

The strongest argument against the current pricing is that Norton's drop was driven by capital flow dynamics, not by any change in the underlying information about his Oscar candidacy. His performance has not been downgraded by critics. No rival in the Supporting Actor category delivered a festival-circuit breakthrough that displaced him. The entire move traces to a reallocation triggered by events in a different race.

If Malkovich's Best Actor odds plateau or decline after Toronto or Telluride screenings introduce new competition, the capital pressure on Norton could reverse. A strong showing at one of the remaining fall festivals, a Screen Actors Guild nomination, or a critics' circle win could independently push Norton back toward 20%.

The counterargument deserves equal weight. Giamatti's dominance is not purely a function of Malkovich-driven reallocation. If Giamatti's performance is genuinely pulling away from the field on its own merits, Norton's prior 20% may have been inflated, and the current 10% may be closer to fair value. Markets do not always overreact. Sometimes a correction looks like a crash.

This contract resolves on March 14, 2027, leaving nearly six months of awards season campaigning, guild voting, and critics' cycles to reshape the field. For live pricing across all contenders, track the Best Supporting Actor odds hub.

The bottom line: Norton's 50-point drop is real, but the cause is external. Whether the market has priced that external pressure correctly or overcorrected will depend on whether Malkovich's dominance holds and whether Norton's own campaign generates momentum independent of the broader Oscar market's center of gravity.